Nelarabine Injection
Product Images NDC 68083-233

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 68083-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nelarabine-spl-carton-label (Nelarabine Spl Carton Label)

Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous infusion carton by Gland Pharma Limited. The sterile, single-dose vial package contains 6 vials of 50 mL each. Label includes dosage strength, cytotoxic agent warning, storage instructions, and manufacturer information with barcode and NDC 68083-233-06.*

FDA Label Image

Nelarabine-spl-structure (Nelarabine Spl Structure)

Chemical structure of Nelarabine, showing its molecular arrangement including a methoxy group, multiple nitrogen atoms in a purine-like ring, an amino group, and a sugar moiety with hydroxyl groups.*

FDA Label Image

Nelarabine-spl-vial-label (Nelarabine Spl Vial Label)

Nelarabine Injection label showing a strength of 250 mg/50 mL (5 mg/mL) for intravenous infusion. The label indicates it is a cytotoxic agent in a sterile 50 mL single-dose vial. Manufactured by Gland Pharma Limited, India, with instructions for storage, dilution, and usage details on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.